Table 12.
Recommendations for raloxifene therapy.
Recommendations | Grading of recommendations | Quality of evidence |
---|---|---|
Postmenopausal osteoporosis with l-spine T-score ≤ −2.5 and no risk of other fracturesa | IIa | A |
Alternative treatment for postmenopausal women at high fracture risk who are not appropriate to use bisphosphonate and denosumab | IIa | A |
Prevention of bone loss in postmenopausal women with risk factor(s) for osteoporosis and breast cancer | IIa | A |
For reduction of vertebral fracture.